Cochrane · systematic review · CD007387
Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies
Charoenkwan, K, Kietpeerakool, C · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 14.3%Moderate 2 · 28.6%High 4 · 57.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Current version onlyRetroperitoneal drainage versus no drainage after pelvic lymphadenectomy for gynaecological malignancies
Population: Women with gynaecological malignancies
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.76 [0.04, 13.35] | 2 studies · 204 participants | Moderate Downgraded: imprecision |
Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 3.25 [1.26, 8.37] | 2 studies · 237 participants | High |
Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.72 [0.3, 1.71] | 2 studies · 180 participants | High |
Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 1.48 [0.89, 2.45] | 1 study · 232 participants | High |
Long‐term lymphocyst formation: symptomatic at 12 months after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 7.12 [0.89, 56.97] | 1 study · 232 participants | Low Downgraded: imprecision |
Febrile morbidity Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 1.76 [0.87, 3.55] | 4 studies · 571 participants | High |
Pelvic infection Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.42 [0.11, 1.62] | 4 studies · 571 participants | Moderate Downgraded: imprecision |
Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for gynaecological malignancies
Population: patients with gynaecological malignancies
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.76 [0.04, 13.35] | 2 studies · 204 participants | High |
Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 3.25 [1.26, 8.37] | 2 studies · 237 participants | High |
Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.72 [0.3, 1.71] | 2 studies · 180 participants | High |
Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 1.48 [0.89, 2.45] | 1 study · 232 participants | High |
Long‐term lymphocyst formation: symptomatic at 12 months after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 7.12 [0.89, 56.97] | 1 study · 232 participants | High |
Febrile morbidity Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 1.76 [0.87, 3.55] | 4 studies · 571 participants | High |
Pelvic infection Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.42 [0.11, 1.62] | 4 studies · 571 participants | High |
Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for gynaecological malignancies
Population: patients with gynaecological malignancies
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.76 [0.04, 13.35] | 2 studies · 204 participants | High |
Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 3.25 [1.26, 8.37] | 2 studies · 237 participants | High |
Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.72 [0.3, 1.71] | 2 studies · 180 participants | High |
Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 1.48 [0.89, 2.45] | 1 study · 232 participants | High |
Long‐term lymphocyst formation: symptomatic at 12 months after surgery Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 7.12 [0.89, 56.97] | 1 study · 232 participants | High |
Febrile morbidity Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 1.76 [0.87, 3.55] | 4 studies · 571 participants | High |
Pelvic infection Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy | RR 0.42 [0.11, 1.62] | 4 studies · 571 participants | High |